Technical Analysis for AVDL - Avadel Pharmaceuticals plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 17.81 | -0.06% | -0.01 |
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| 20 DMA Support | Bullish | -0.06% | |
| 180 Bullish Setup | Bullish Swing Setup | -0.06% | |
| Upper Bollinger Band Walk | Strength | 0.85% | |
| Upper Bollinger Band Touch | Strength | 0.85% | |
| Upper Bollinger Band Touch | Strength | -1.55% | |
| 20 DMA Support | Bullish | 2.95% | |
| Down 3 Days in a Row | Weakness | 2.95% | |
| Down 4 Days in a Row | Weakness | 2.95% | |
| Upper Bollinger Band Walk | Strength | 2.77% |
| Alert | Time |
|---|---|
| Possible NR7 | about 12 hours ago |
| Up 2% | about 16 hours ago |
| Bullish 180 Entry | about 16 hours ago |
| Rose Above Previous Day's High | about 16 hours ago |
| Up 1% | about 16 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/06/2024
Avadel Pharmaceuticals plc Description
Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Organ Systems Drugs Surgery Psychoactive Drugs Chloride Reversal Amines Anesthesia Sleep Disorders Narcolepsy Choline Phenols Cataplexy Cholinesterase Phenylephrine Muscle Relaxants
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.85 |
| 52 Week Low | 9.5 |
| Average Volume | 1,261,785 |
| 200-Day Moving Average | 13.63 |
| 50-Day Moving Average | 15.89 |
| 20-Day Moving Average | 17.06 |
| 10-Day Moving Average | 17.65 |
| Average True Range | 0.93 |
| RSI (14) | 59.84 |
| ADX | 24.72 |
| +DI | 27.15 |
| -DI | 17.58 |
| Chandelier Exit (Long, 3 ATRs) | 16.06 |
| Chandelier Exit (Short, 3 ATRs) | 18.04 |
| Upper Bollinger Bands | 18.44 |
| Lower Bollinger Band | 15.68 |
| Percent B (%b) | 0.77 |
| BandWidth | 16.19 |
| MACD Line | 0.49 |
| MACD Signal Line | 0.47 |
| MACD Histogram | 0.0262 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.58 | ||||
| Resistance 3 (R3) | 18.63 | 18.42 | 18.45 | ||
| Resistance 2 (R2) | 18.42 | 18.23 | 18.40 | 18.40 | |
| Resistance 1 (R1) | 18.12 | 18.11 | 18.02 | 18.07 | 18.36 |
| Pivot Point | 17.91 | 17.91 | 17.86 | 17.89 | 17.91 |
| Support 1 (S1) | 17.61 | 17.72 | 17.51 | 17.56 | 17.26 |
| Support 2 (S2) | 17.40 | 17.60 | 17.38 | 17.22 | |
| Support 3 (S3) | 17.10 | 17.40 | 17.17 | ||
| Support 4 (S4) | 17.05 |
